Form 8-K - Current report:
SEC Accession No. 0000926617-20-000046
Filing Date
2020-06-11
Accepted
2020-06-11 09:18:06
Documents
5
Period of Report
2020-06-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrml-20200611x8k.htm 8-K 50404
2 EX-3.1 vrml-20200611xex3_1.htm EX-3.1 13456
3 EX-3.2 vrml-20200611xex3_2.htm EX-3.2 533521
4 EX-99.1 vrml-20200611xex99_1.htm EX-99.1 13872
5 GRAPHIC vrml-20200611xex99_1g001.jpg GRAPHIC 135062
  Complete submission text file 0000926617-20-000046.txt   798934
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 20956315
SIC: 2835 In Vitro & In Vivo Diagnostic Substances